Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun;132(3):443-9.
doi: 10.1046/j.1365-2249.2003.02172.x.

The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis

Affiliations

The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis

J-S Lee et al. Clin Exp Immunol. 2003 Jun.

Abstract

The clearance of intracellular bacteria requires the appropriate induction of proinflammatory cytokines and chemokines to recruit macrophages and T cells to the site of infection. In this study, we investigated the production of tumour necrosis factor (TNF)-alpha, interleukin (IL)-8 and interferon (IFN)-gamma by the peripheral blood mononuclear cells (PBMC) of patients with multidrug-resistant tuberculosis (MDR-TB) in response to in vitro stimulation with the 30-kDa antigen of Mycobacterium tuberculosis. The results were compared with those from cases of newly diagnosed TB (N-TB) and TB with treatment failure (TF-TB), and healthy tuberculin reactors (HTR). The most significantly depressed TNF-alpha levels were found in MDR-TB patients. IFN-gamma production was depressed significantly in all groups of TB patients compared with the HTR group. TNF-alpha secretion in response to the 30-kDa antigen was unchanged by coculturing with recombinant human interferon (rhIFN)-gamma, and was increased dramatically following IL-10 neutralization with an anti-human IL-10 antibody. The IL-8 levels were depressed significantly in MDR-TB patients compared with N-TB patients, but were similar to the IL-8 levels in TF-TB patients. Furthermore, rhTNF-alpha directly increased IL-8 secretion, and neutralizing antibody to TNF-alpha inhibited IL-8 production by the PBMC of MDR-TB patients that were stimulated with the 30-kDa antigen. Taken together, these data suggest that the PBMC of MDR-TB patients typically show TNF-alpha depression in response to the 30-kDa antigen, and this effect is modulated by IL-10. In addition, we highlight the role of TNF-alpha in IL-8 secretion in MDR-TB patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
TNF-α and IFN-γ production by PBMCs from TB patients and HTR after in vitro stimulation with the 30-kDa Ag of M. tuberculosis. The PBMCs were stimulated with the 30-kDa Ag, and the supernatant harvested after 18 and 96 h, respectively. Secreted TNF-α and IFN-γ levels in the culture supernatants were measured by ELISA, as described in Materials and methods. The TNF-α (a), IFN-γ (b) and IL-10 (c) levels in PBMCs from each group of TB patients and HTR were determined after in vitro stimulation with the 30-kDa Ag. The values are shown as the mean ± s.d. of triplicate supernatant samples. The data are from one representative experiment. *P < 0·05; **P < 0·01; ***P < 0·001 (Student's t-test).
Fig. 2
Fig. 2
The effect of rhIFN-γ or endogenous IL-10 on TNF-α induction by the 30-kDa Ag of M. tuberculosis. PBMC from HTR (n = 5) and MDR-TB patients (n = 5) were cultured with or without rhIFN-γ, neutralizing antibody to IL-10 (2 µg/ml), or control antibody (2 µg/ml). The 30-kDa Ag (1 µg/ml) was added to each of the cultures. Immunoreactivity for TNF-α was assessed in the culture supernatants at 18 h. The data are the mean ± s.d. of a representative result of three independent experiments. The percentage increase in TNF-α immunoreactivity relative to the TNF-α level of a culture that was treated with the 30-kDa Ag alone (100%) is shown. □, 30-kDa only; formula image, 30-kDa + rhIFN-γ; ▪, 30-kDa + α-IL-10; formula image, 30-kDa + control IgG.
Fig. 3
Fig. 3
IL-8 production by PBMC from TB patients and HTR in response to the 30-kDa Ag of M. tuberculosis. (a) IL-8 production in TB patients and HTR. The supernatants were prepared after 96 h, and the cytokine concentrations were measured by ELISA. The values shown are the mean ± s.d. of triplicate supernatant samples. The data are from one representative experiment. (b) There was significant correlation between the IL-8 and TNF-α levels in 30-kDa Ag-stimulated PBMCs from TB patients (n = 57, r = 0·58, P < 0·001), but not those from HTR controls (n = 20, r = 0·17, P > 0·1). •, HTR; , HTR reg; r, TB; ···, TB reg.
Fig. 4
Fig. 4
Effect of IFN-γ and TNF-α on 30-kDa Ag-induced IL-8 production by PBMC of MDR-TB patients. (a) Effect of rhIFN-γ or rhTNF-α (each 10 ng/ml) on IL-8 production induced by the 30-kDa Ag. PBMC from HTR (n = 7) were cultured with or without rhIFN-γ, rhTNF-α, rhIFN-γ+ rhTNF-α, rhIFN-γ+ anti-TNF-α antibody or rhIFN-γ+ control antibody. Then 30-kDa Ag (1 µg/ml) was added to each of the cultures. The culture supernatants were collected at 96 h and assayed for IL-8 production by ELISA. The percentage increase in IL-8 immunoreactivity relative to the IL-8 level of a culture that was treated with 30-kDa Ag alone (100%) is shown. (b) Effect of endogenous TNF-α on IL-8 production that was induced by the 30-kDa Ag. PBMC from HTR (n = 7) were stimulated with the 30-kDa Ag and cultured with or without neutralizing antibody to TNF-α (2 µg/ml) or control antibody (2 µg/ml). The percentage increase in IL-8 immunoreactivity relative to the IL-8 level of a culture that was treated with 30-kDa Ag alone is shown. (c) Effects of rhTNF-α on 30-kDa Ag-induced IL-8 production by PBMC from MDR-TB patients (n = 7). The data are representative of three separate experiments. ▪, 30-kDa; □, 30-kDa + rhTNF-α.

References

    1. Raviglione MC, Snider DE, Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220–6. - PubMed
    1. McDyer JF, Hackley MN, Walsh TE, Cook JL, Seder RA. Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. J Immunol. 1997;158:492–500. - PubMed
    1. Lee JS, Song CH, Kim CH, et al. Profiles of IFN-γ and its regulatory cytokines (IL-12, IL-18, and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol. 2002;128:516–24. - PMC - PubMed
    1. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098–104. - PubMed
    1. Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2:561–72. - PubMed

Publication types

MeSH terms